Strategies to modify levodopa treatment.
Widner
Håkan
H
Department of Clinical Neurosciences, Wallenberg Neuroscience Center, Lund University Hospital, Lund, Sweden.
D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D004347:Drug Interactions / Q000502:physiology; D004351:Drug Resistance / Q000502:physiology; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology
D000978:Antiparkinson Agents; D007980:Levodopa